Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 28, 2017
What are the generic drug sources for escitalopram oxalate and what is the scope of escitalopram oxalate freedom to operate?
Escitalopram oxalate is the generic ingredient in two branded drugs marketed by Invagen Pharms, Macleods Pharms Ltd, Sti Pharma Llc, Amneal Pharms, Hetero Labs Ltd Iii, Taro, Forest Labs, Aurobindo Pharma Ltd, Prinston Inc, Zydus Pharms Usa Inc, Torrent Pharms Ltd, Mylan Pharms Inc, Teva Pharms Usa, Hikma Pharms, Antrim Pharms Llc, Lupin Ltd, Silarx Pharms Inc, Apotex Inc, Jubilant Generics, and Accord Hlthcare, and is included in twenty-five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.| Tradenames: | 2 |
| Patents: | 2 |
| Applicants: | 20 |
| NDAs: | 25 |
| Drug Master File Entries: see list | 25 |
| Suppliers / Packagers: see list | 58 |
| Bulk Api Vendors: see list | 68 |
| Clinical Trials: see list | 319 |
| Patent Applications: see list | 599 |
| Therapeutic Class: | Anxiolytics |
| Drug Prices: | see low prices |
| DailyMed Link: | escitalopram oxalate at DailyMed |
| Drug Class | Serotonin Reuptake Inhibitor |
| Mechanism of Action | Serotonin Uptake Inhibitors |
| Applicant | Application No. | Strength | Dosage Form |
| ► Subscribe | ► Subscribe | 5MG | TABLET; ORAL |
| ► Subscribe | ► Subscribe | 20MG | TABLET; ORAL |
| ► Subscribe | ► Subscribe | 10MG | TABLET; ORAL |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | ESCITALOPRAM OXALATE | escitalopram oxalate | SOLUTION;ORAL | 079121-001 | May 3, 2012 | AA | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Accord Hlthcare | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202389-002 | Sep 11, 2012 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Forest Labs | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | AB | RX | Yes | No | ► Subscribe | ► Subscribe | Y | ► Subscribe | ||||||||||||||||
Jubilant Generics | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202280-002 | Sep 12, 2012 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
Accord Hlthcare | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 202389-003 | Sep 11, 2012 | AB | RX | No | No | ► Subscribe | ► Subscribe | ► Subscribe | |||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Labs | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-001 | Aug 14, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Forest Labs | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-002 | Aug 14, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Forest Labs | LEXAPRO | escitalopram oxalate | TABLET;ORAL | 021323-003 | Aug 14, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
Forest Labs | LEXAPRO | escitalopram oxalate | SOLUTION;ORAL | 021365-001 | Nov 27, 2002 | ► Subscribe | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,080 others who get our Drug Patent Expiration Alerts:
